Matrika Eye Center, Dhunge Dhara Marg, Ward number 9, Kathmandu, 44600, Nepal.
SCHWIND eye-tech-solutions, Mainparkstr. 6-10, Kleinostheim, 63801, Germany.
BMC Ophthalmol. 2023 Jul 18;23(1):328. doi: 10.1186/s12886-023-03076-z.
Impact of low energy asymmetric spacings vs. high energy symmetric spacings on the immediate/early (postoperative day 1 (POD1)) outcomes of SmartSight lenticule extraction for myopic astigmatism with a new femtosecond laser system.
The first 112 eyes of 56 patients consecutively treated using low energy asymmetric spacings (Group A; Study group) were compared at POD1 to the last 112 eyes of 56 patients consecutively treated using high energy symmetric spacings (Group S; Controls). Mean age of the patients was 28 ± 5 years with a mean spherical equivalent of -4.41 ± 1.76 diopters (D) and a mean magnitude of refractive astigmatism of 0.89 ± 0.82 D.
Laser Energy was -25 ± 1nJ lower for asymmetric treatments (p < .0001); Spot and Track distances were + 0.7 ± 0.1 µm larger and -0.8 ± 0.1 µm tighter for asymmetric treatments, respectively (p < .0001 for both). At POD1, astigmatism was -0.08 ± 0.02D lower for asymmetric treatments (p < .0003); uncorrected and corrected visual acuities (UDVA and CDVA, respectively) were -0.03 ± 0.01logMAR better for asymmetric treatments (p < .0007); differences between postop UDVA and preop CDVA along with change in CDVA were + 0.3 ± 0.1lines better for asymmetric treatments (p < .0003).
Lenticule extraction treatment using SmartSight is safe and efficacious already at POD1. Findings suggest that low energy asymmetric spacings may further improve the immediate and short-term outcomes of SmartSight lenticule extraction in the treatment of myopic astigmatism compared to conventional settings (high energy symmetric spacings).
使用新的飞秒激光系统,对于近视散光的 SmartSight 透镜提取,低能量非对称间隔与高能量对称间隔对即刻/早期(术后第 1 天(POD1))结果的影响。
连续治疗 56 例患者的前 112 只眼(A 组;研究组)采用低能量非对称间隔,与连续治疗 56 例患者的后 112 只眼(S 组;对照组)进行比较。患者平均年龄为 28±5 岁,平均等效球镜度数为-4.41±1.76 屈光度(D),平均屈光性散光为 0.89±0.82 D。
非对称治疗的激光能量低 25±1nJ(p<0.0001);光斑和轨道距离分别大 0.7±0.1µm(p<0.0001)和小 0.8±0.1µm(p<0.0001)。在 POD1,非对称治疗的散光低 0.08±0.02D(p<0.0003);未矫正和矫正视力(UDVA 和 CDVA,分别)分别好 0.03±0.01logMAR(p<0.0007);非对称治疗的术后 UDVA 与术前 CDVA 之间的差异以及 CDVA 的变化均好 0.3±0.1 行(p<0.0003)。
SmartSight 透镜提取术在 POD1 时已安全有效。研究结果表明,与传统设置(高能量对称间隔)相比,低能量非对称间隔可能进一步改善 SmartSight 透镜提取术治疗近视散光的即刻和短期结果。